Rezultati pretrage - Jan Gerstoft

Detaljiziraj rezultate
  1. 1
    Can chemoprophylaxis against opportunistic infections be discontinued after an increase in CD4 cells induced by highly active antiretroviral therapy?

    Can chemoprophylaxis against opportunistic infections be discontinued after an increase in CD4 cells induced by highly active antiretroviral therapy? od Ole Kirk, Jens Lundgren, Court Pedersen, Henrik Nielsen, Jan Gerstoft

    Izdano 1999
    Preuzmi cijeli tekst
    Artigo
    Spremi u popis
    Spremljeno u:
  2. 2
    Improved survival in HIV-infected persons: consequences and perspectives

    Improved survival in HIV-infected persons: consequences and perspectives od Nicolai Lohse, Ann‐Brit Eg Hansen, Jan Gerstoft, Niels Obel

    Izdano 2007
    Preuzmi cijeli tekst Preuzmi cijeli tekst
    Artigo
    Spremi u popis
    Spremljeno u:
  3. 3
    Incomplete Immune Recovery in HIV Infection: Mechanisms, Relevance for Clinical Care, and Possible Solutions

    Incomplete Immune Recovery in HIV Infection: Mechanisms, Relevance for Clinical Care, and Possible Solutions od Julie C. Gaardbo, Hans Jakob Hartling, Jan Gerstoft, Susanne Dam Nielsen

    Izdano 2012
    Preuzmi cijeli tekst Preuzmi cijeli tekst
    Revisão
    Spremi u popis
    Spremljeno u:
  4. 4
    Syphilis and Human Immunodeficiency Virus (HIV)-1 Coinfection: Influence on CD4 T-Cell Count, HIV-1 Viral Load, and Treatment Response

    Syphilis and Human Immunodeficiency Virus (HIV)-1 Coinfection: Influence on CD4 T-Cell Count, HIV-1 Viral Load, and Treatment Response od Klaus F. Kofoed, Jan Gerstoft, Peter M. H. Heegaard, Thomas Benfield

    Izdano 2006
    Preuzmi cijeli tekst
    Artigo
    Spremi u popis
    Spremljeno u:
  5. 5
    Thirty Years with HIV Infection—Nonprogression Is Still Puzzling: Lessons to Be Learned from Controllers and Long-Term Nonprogressors

    Thirty Years with HIV Infection—Nonprogression Is Still Puzzling: Lessons to Be Learned from Controllers and Long-Term Nonprogressors od Julie C. Gaardbo, Hans Jakob Hartling, Jan Gerstoft, Susanne Dam Nielsen

    Izdano 2012
    Preuzmi cijeli tekst Preuzmi cijeli tekst
    Artigo
    Spremi u popis
    Spremljeno u:
  6. 6
    Testing the hypothesis that treatment can eliminate HIV: a nationwide, population-based study of the Danish HIV epidemic in men who have sex with men

    Testing the hypothesis that treatment can eliminate HIV: a nationwide, population-based study of the Danish HIV epidemic in men who have sex with men od Justin T Okano, Danielle Robbins, Laurence Palk, Jan Gerstoft, Niels Obel, Sally Blower

    Izdano 2016
    Preuzmi cijeli tekst
    Artigo
    Spremi u popis
    Spremljeno u:
  7. 7
    Persistent Inflammation and Endothelial Activation in HIV-1 Infected Patients after 12 Years of Antiretroviral Therapy

    Persistent Inflammation and Endothelial Activation in HIV-1 Infected Patients after 12 Years of Antiretroviral Therapy od Frederikke F. Rönsholt, Henrik Ullum, Terese L. Katzenstein, Jan Gerstoft, Sisse Rye Ostrowski

    Izdano 2013
    Preuzmi cijeli tekst Preuzmi cijeli tekst
    Artigo
    Spremi u popis
    Spremljeno u:
  8. 8
    Course and Clinical Significance of CD8<sup>+</sup>T-Cell Counts in a Large Cohort of HIV-Infected Individuals

    Course and Clinical Significance of CD8<sup>+</sup>T-Cell Counts in a Large Cohort of HIV-Infected Individuals od Marie Helleberg, Gitte Kronborg, Henrik Ullum, Lars P. Ryder, Niels Obel, Jan Gerstoft

    Izdano 2014
    Preuzmi cijeli tekst
    Artigo
    Spremi u popis
    Spremljeno u:
  9. 9
    Risk of Diabetes Mellitus in Persons with and without HIV: A Danish Nationwide Population-Based Cohort Study

    Risk of Diabetes Mellitus in Persons with and without HIV: A Danish Nationwide Population-Based Cohort Study od Line Dahlerup Rasmussen, Elisabeth R. Mathiesen, Gitte Kronborg, Court Pedersen, Jan Gerstoft, Niels Obel

    Izdano 2012
    Preuzmi cijeli tekst Preuzmi cijeli tekst
    Artigo
    Spremi u popis
    Spremljeno u:
  10. 10
    Statin Therapy and Mortality in HIV-Infected Individuals; A Danish Nationwide Population-Based Cohort Study

    Statin Therapy and Mortality in HIV-Infected Individuals; A Danish Nationwide Population-Based Cohort Study od Line Dahlerup Rasmussen, Gitte Kronborg, Carsten Schade Larsen, Court Pedersen, Jan Gerstoft, Niels Obel

    Izdano 2013
    Preuzmi cijeli tekst Preuzmi cijeli tekst
    Artigo
    Spremi u popis
    Spremljeno u:
  11. 11
    Temporal relation of antigenaemia and loss of antibodies to core antigens to development of clinical disease in HIV infection.

    Temporal relation of antigenaemia and loss of antibodies to core antigens to development of clinical disease in HIV infection. od C. Pedersen, C. M. Nielsen, Bent Faber Vestergaard, Jan Gerstoft, Kim Krogsgaard, Jens Nielsen

    Izdano 1987
    Preuzmi cijeli tekst Preuzmi cijeli tekst
    Artigo
    Spremi u popis
    Spremljeno u:
  12. 12
    CD4 Decline Is Associated With Increased Risk of Cardiovascular Disease, Cancer, and Death in Virally Suppressed Patients With HIV

    CD4 Decline Is Associated With Increased Risk of Cardiovascular Disease, Cancer, and Death in Virally Suppressed Patients With HIV od Marie Helleberg, Gitte Kronborg, Carsten Schade Larsen, Gitte Pedersen, Court Pedersen, Niels Obel, Jan Gerstoft

    Izdano 2013
    Preuzmi cijeli tekst
    Artigo
    Spremi u popis
    Spremljeno u:
  13. 13
    Risk of cerebrovascular events in persons with and without HIV

    Risk of cerebrovascular events in persons with and without HIV od Line Dahlerup Rasmussen, Frederik Neess Engsig, Hanne Christensen, Jan Gerstoft, Gitte Kronborg, Court Pedersen, Niels Obel

    Izdano 2011
    Preuzmi cijeli tekst
    Artigo
    Spremi u popis
    Spremljeno u:
  14. 14
    Combination therapy containing ritonavir plus saquinavir has superior short-term antiretroviral efficacy: a randomized trial

    Combination therapy containing ritonavir plus saquinavir has superior short-term antiretroviral efficacy: a randomized trial od Ole Kirk, Terese L. Katzenstein, Jan Gerstoft, Peter M. H. Heegaard, Henrik Nielsen, Court Pedersen, Jens Lundgren

    Izdano 1999
    Preuzmi cijeli tekst
    Artigo
    Spremi u popis
    Spremljeno u:
  15. 15
    Incidence of low and high-energy fractures in persons with and without HIV infection

    Incidence of low and high-energy fractures in persons with and without HIV infection od Ann‐Brit Eg Hansen, Jan Gerstoft, Gitte Kronborg, Carsten Schade Larsen, Court Pedersen, Gitte Pedersen, Niels Obel

    Izdano 2011
    Preuzmi cijeli tekst
    Artigo
    Spremi u popis
    Spremljeno u:
  16. 16
    The relative prognostic value of plasma HIV RNA levels and CD4 lymphocyte counts in advanced HIV infection

    The relative prognostic value of plasma HIV RNA levels and CD4 lymphocyte counts in advanced HIV infection od Alessandro Cozzi‐Lepri, Terese L. Katzenstein, Henrik Ullum, Andrew Phillips, Peter Skinhøj, Jan Gerstoft, Bente Klarlund Pedersen

    Izdano 1998
    Preuzmi cijeli tekst
    Artigo
    Spremi u popis
    Spremljeno u:
  17. 17
    A Highly Selective Cc Chemokine Receptor (Ccr)8 Antagonist Encoded by the Poxvirus Molluscum Contagiosum

    A Highly Selective Cc Chemokine Receptor (Ccr)8 Antagonist Encoded by the Poxvirus Molluscum Contagiosum od Hans Rudolf Lüttichau, Johnny T. Stine, Thomas Boesen, Anders H. Johnsen, David Chantry, Jan Gerstoft, Thue W. Schwartz

    Izdano 2000
    Preuzmi cijeli tekst Preuzmi cijeli tekst
    Artigo
    Spremi u popis
    Spremljeno u:
  18. 18
    The influence of HTLV-III infection on the natural history of hepatitis B virus infection in male homosexual HBsAg carriers

    The influence of HTLV-III infection on the natural history of hepatitis B virus infection in male homosexual HBsAg carriers od Kim Krogsgaard, Bjarne Ørskov Lindhardt, Jens Ole Nielsen, Poul Andersson, Peter Kryger, Jan Aldershvile, Jan Gerstoft, Court Pedersen

    Izdano 1987
    Preuzmi cijeli tekst Preuzmi cijeli tekst
    Artigo
    Spremi u popis
    Spremljeno u:
  19. 19
    Impact of Non-HIV and HIV Risk Factors on Survival in HIV-Infected Patients on HAART: A Population-Based Nationwide Cohort Study

    Impact of Non-HIV and HIV Risk Factors on Survival in HIV-Infected Patients on HAART: A Population-Based Nationwide Cohort Study od Niels Obel, Lars Haukali Omland, Gitte Kronborg, Carsten Schade Larsen, Court Pedersen, Gitte Pedersen, Henrik Toft Sørensen, Jan Gerstoft

    Izdano 2011
    Preuzmi cijeli tekst Preuzmi cijeli tekst
    Artigo
    Spremi u popis
    Spremljeno u:
  20. 20
    Low efficacy and high frequency of adverse events in a randomized trial of the triple nucleoside regimen abacavir, stavudine and didanosine

    Low efficacy and high frequency of adverse events in a randomized trial of the triple nucleoside regimen abacavir, stavudine and didanosine od Jan Gerstoft, Ole Kirk, Niels Obel, Court Pedersen, Peter M. H. Heegaard, Henrik Nielsen, Terese L. Katzenstein, Jens Lundgren

    Izdano 2003
    Preuzmi cijeli tekst
    Artigo
    Spremi u popis
    Spremljeno u:

Alati za pretragu: